Global Invivo Imaging Market

Invivo Imaging Comprehensive Study by Application (Morphological, Molecular), Technology (PET (Positron Emission Tomography), Diffuse Optical Tomography (DOT), Biomakers, Other), End Use (Imaging & Diagnostics Centers, Hospitals & Clinics, Research Institutes), Material Used (Optical, Nuclear, Others) Players and Region - Global Market Outlook to 2027

Invivo Imaging Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Invivo Imaging?
In vivo imaging is the non-invasive visualization of living organisms for research and diagnostic purposes. Different material are used to visualize cellular and molecular functioning of living organisms. Biomarkers, radioactive materials like radioisotopes are used for molecular imaging. In vivo research comprises of the observing and visualising all molecular processes with or within an entire, living organism. Study of animal models or human clinical trials are majorly demands for In vivo imaging techniques. This method is differentiated into two key areas morphological imaging and molecular imaging. Molecular imaging involves visualisation of cellular functions by using biomarkers. However, anatomical imaging visualization is based on the fundamental properties of the tissues and organs. This tissue and organs are observed by of X-rays & computed tomography. This is use to study morphological and molecular changes, process in targeted delivery of drugs, toxins, enzymes, or DNA research applications. Augmenting new launching of diagnostics kits & wide applicability in number of therapeutic areas leads to the demand for In vivo imaging globally. Further, the demand for In vivo imaging has been raised particularly for cancer diagnosis and oncological drugs diagnostics. Thus raised expenditure for cancer research and treatments impacts on the demand in positive manner. For Instance, according to the study, in 2018 the global expenditure on cancer research was USD 150 billion and it is expected to rise in upcoming years.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)
Key Companies ProfiledTriFoil Imaging (United States), Berthold Technologies GmbH & Co.KG (Germany), New England Biolabs. (United Kingdom), Bruker (United States), Promega Corporation. (United States), ThermoFisher Scientific (United States), PerkinElmer Inc.(United States), AbbVie Inc. (United States), DiscoveRx Corporation (United States), Biospace Lab S.A. (France) and MILabs B.V. (Netherland)


The study covers a detailed analysis segmented by key business segments i.e. , by application (Morphological and Molecular) and major geographies. Research Analyst at AMA predicts that North America Players will contribute to the maximum growth of Global Invivo Imaging market throughout the predicted period.

The competition is expected to become even more intense in the years to come due to the entry of several new players in the market. To help clients improve their revenue shares in the market, this research study provides an in-depth analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this Invivo Imaging market report suggests strategies that Players can follow and highlights key areas they should focus on, in order to take maximum benefits of growth opportunities.

The report offers several leading Players, some of them are TriFoil Imaging (United States), Berthold Technologies GmbH & Co.KG (Germany), New England Biolabs. (United Kingdom), Bruker (United States), Promega Corporation. (United States), ThermoFisher Scientific (United States), PerkinElmer Inc.(United States), AbbVie Inc. (United States), DiscoveRx Corporation (United States), Biospace Lab S.A. (France) and MILabs B.V. (Netherland).

Market Overview:
Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, In February 2022 announced a partnership with New England Biolabs (NEB®) to commercially develop and launch products to enable compatibility of the NEBNext Ultra II portfolio with the Element AVITI System.

The market of In Vivo Imaging is expected to grow with rising demand for Onco based diagnosis and clinical trials. Market specifically witnessing huge demand owing to rising clinical trials. There are various companies are operating in the market to provides excellent diagnosis kits with in vivo imaging for oncology and other therapeutic areas. Major players in the industry are gaining attention from the market. There are various market players are entering in this industry to capture market growth opportunities. The market leaders are investing on organic and non-organic strategic growth initiatives to become dominant in this industry.

Market Trend
Growing Advances in Imaging and Diagnostics
Restraints
  • High Cost Associated with Instruments and their Maintenance

Opportunities
Technological Advancements with the AI & Machine Learning Approaches for Preclinical Imaging Has Created Ample Opportunities

Key highlights of the Global Invivo Imaging market Study:
• CAGR of the market during the forecast period 2021-2027
• In-depth information on growth factors that will accelerate the Invivo Imaging market in next few years.
• Detailed Insights on futuristic trends and changing consumer behaviour
• Forecast of the Global Invivo Imaging market size and its contribution to the parent market by type, application and by country.
• A broad view of customer demand
• Uncover market’s competitive landscape and in-depth information on various Players
• Comprehensive information about factors that will challenge the growth of Invivo Imaging Players

Transformation and Important Triggers:
Business transformation has taken hold across the broad corporate landscape due to the confluence of several important triggers, including:
• A tipping point in globalization
• A major slowdown in Western economies
• Significant shifts in technology and cost structure
• The challenges of regulatory compliance
• New forms of competition developing

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Invivo Imaging market.
In order to reach an exhaustive list of functional and relevant players, various industry classification standards are closely followed such as NAICS, ICB, and SIC to penetrate deep into important geographies by players, and a thorough validation test is conducted to reach the most relevant players for survey in Invivo Imaging market.
In order to make a priority list sorting is done based on revenue generated based on the latest reporting, using paid databases such as Factiva, Bloomberg, etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment> by targeting key target audience that includes In Vivo imaging techniques Manufacturers/Suppliers/Distributor, Medicinal Research Organizations, New Entrants/Investors, Strategic Business Planners, Government Regulatory and End Use Industry.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth, etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that include Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases, etc.

Report Objectives / Segmentation Covered

By Application
  • Morphological
  • Molecular
By Technology
  • PET (Positron Emission Tomography)
  • Diffuse Optical Tomography (DOT)
  • Biomakers
  • Other

By End Use
  • Imaging & Diagnostics Centers
  • Hospitals & Clinics
  • Research Institutes

By Material Used
  • Optical
  • Nuclear
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Preference for the Use of Luminescent Proteins as Fluorescent agent is Driving the Demand for the InVivo Imaging
      • 3.2.2. Raised Expenditure of Healthcare Industry particularly for Diagnostics
      • 3.2.3. Growing Spending’s on Cancer Research and Developments of InVivo Imaging Techniques
    • 3.3. Market Challenges
      • 3.3.1. Lack of Technically Keen Personnel
      • 3.3.2. Limited Penetration of Advanced InVivo Imaging in Emerging Regions
    • 3.4. Market Trends
      • 3.4.1. Growing Advances in Imaging and Diagnostics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Invivo Imaging, by Application, Technology, End Use, Material Used and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Invivo Imaging (Value)
      • 5.2.1. Global Invivo Imaging by: Application (Value)
        • 5.2.1.1. Morphological
        • 5.2.1.2. Molecular
      • 5.2.2. Global Invivo Imaging by: Technology (Value)
        • 5.2.2.1. PET (Positron Emission Tomography)
        • 5.2.2.2. Diffuse Optical Tomography (DOT)
        • 5.2.2.3. Biomakers
        • 5.2.2.4. Other
      • 5.2.3. Global Invivo Imaging by: End Use (Value)
        • 5.2.3.1. Imaging & Diagnostics Centers
        • 5.2.3.2. Hospitals & Clinics
        • 5.2.3.3. Research Institutes
      • 5.2.4. Global Invivo Imaging by: Material Used (Value)
        • 5.2.4.1. Optical
        • 5.2.4.2. Nuclear
        • 5.2.4.3. Others
      • 5.2.5. Global Invivo Imaging Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Invivo Imaging: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. TriFoil Imaging (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Berthold Technologies GmbH & Co.KG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. New England Biolabs. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bruker (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Promega Corporation. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ThermoFisher Scientific (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PerkinElmer Inc.(United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. AbbVie Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. DiscoveRx Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Biospace Lab S.A. (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. MILabs B.V. (Netherland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Invivo Imaging Sale, by Application, Technology, End Use, Material Used and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Invivo Imaging (Value)
      • 7.2.1. Global Invivo Imaging by: Application (Value)
        • 7.2.1.1. Morphological
        • 7.2.1.2. Molecular
      • 7.2.2. Global Invivo Imaging by: Technology (Value)
        • 7.2.2.1. PET (Positron Emission Tomography)
        • 7.2.2.2. Diffuse Optical Tomography (DOT)
        • 7.2.2.3. Biomakers
        • 7.2.2.4. Other
      • 7.2.3. Global Invivo Imaging by: End Use (Value)
        • 7.2.3.1. Imaging & Diagnostics Centers
        • 7.2.3.2. Hospitals & Clinics
        • 7.2.3.3. Research Institutes
      • 7.2.4. Global Invivo Imaging by: Material Used (Value)
        • 7.2.4.1. Optical
        • 7.2.4.2. Nuclear
        • 7.2.4.3. Others
      • 7.2.5. Global Invivo Imaging Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Invivo Imaging: by Application(USD Million)
  • Table 2. Invivo Imaging Morphological , by Region USD Million (2016-2021)
  • Table 3. Invivo Imaging Molecular , by Region USD Million (2016-2021)
  • Table 4. Invivo Imaging: by Technology(USD Million)
  • Table 5. Invivo Imaging PET (Positron Emission Tomography) , by Region USD Million (2016-2021)
  • Table 6. Invivo Imaging Diffuse Optical Tomography (DOT) , by Region USD Million (2016-2021)
  • Table 7. Invivo Imaging Biomakers , by Region USD Million (2016-2021)
  • Table 8. Invivo Imaging Other , by Region USD Million (2016-2021)
  • Table 9. Invivo Imaging: by End Use(USD Million)
  • Table 10. Invivo Imaging Imaging & Diagnostics Centers , by Region USD Million (2016-2021)
  • Table 11. Invivo Imaging Hospitals & Clinics , by Region USD Million (2016-2021)
  • Table 12. Invivo Imaging Research Institutes , by Region USD Million (2016-2021)
  • Table 13. Invivo Imaging: by Material Used(USD Million)
  • Table 14. Invivo Imaging Optical , by Region USD Million (2016-2021)
  • Table 15. Invivo Imaging Nuclear , by Region USD Million (2016-2021)
  • Table 16. Invivo Imaging Others , by Region USD Million (2016-2021)
  • Table 17. South America Invivo Imaging, by Country USD Million (2016-2021)
  • Table 18. South America Invivo Imaging, by Application USD Million (2016-2021)
  • Table 19. South America Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 20. South America Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 21. South America Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 22. Brazil Invivo Imaging, by Application USD Million (2016-2021)
  • Table 23. Brazil Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 24. Brazil Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 25. Brazil Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 26. Argentina Invivo Imaging, by Application USD Million (2016-2021)
  • Table 27. Argentina Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 28. Argentina Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 29. Argentina Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 30. Rest of South America Invivo Imaging, by Application USD Million (2016-2021)
  • Table 31. Rest of South America Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 32. Rest of South America Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 33. Rest of South America Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 34. Asia Pacific Invivo Imaging, by Country USD Million (2016-2021)
  • Table 35. Asia Pacific Invivo Imaging, by Application USD Million (2016-2021)
  • Table 36. Asia Pacific Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 37. Asia Pacific Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 38. Asia Pacific Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 39. China Invivo Imaging, by Application USD Million (2016-2021)
  • Table 40. China Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 41. China Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 42. China Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 43. Japan Invivo Imaging, by Application USD Million (2016-2021)
  • Table 44. Japan Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 45. Japan Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 46. Japan Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 47. India Invivo Imaging, by Application USD Million (2016-2021)
  • Table 48. India Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 49. India Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 50. India Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 51. South Korea Invivo Imaging, by Application USD Million (2016-2021)
  • Table 52. South Korea Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 53. South Korea Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 54. South Korea Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 55. Taiwan Invivo Imaging, by Application USD Million (2016-2021)
  • Table 56. Taiwan Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 57. Taiwan Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 58. Taiwan Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 59. Australia Invivo Imaging, by Application USD Million (2016-2021)
  • Table 60. Australia Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 61. Australia Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 62. Australia Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Invivo Imaging, by Application USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 66. Rest of Asia-Pacific Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 67. Europe Invivo Imaging, by Country USD Million (2016-2021)
  • Table 68. Europe Invivo Imaging, by Application USD Million (2016-2021)
  • Table 69. Europe Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 70. Europe Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 71. Europe Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 72. Germany Invivo Imaging, by Application USD Million (2016-2021)
  • Table 73. Germany Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 74. Germany Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 75. Germany Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 76. France Invivo Imaging, by Application USD Million (2016-2021)
  • Table 77. France Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 78. France Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 79. France Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 80. Italy Invivo Imaging, by Application USD Million (2016-2021)
  • Table 81. Italy Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 82. Italy Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 83. Italy Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 84. United Kingdom Invivo Imaging, by Application USD Million (2016-2021)
  • Table 85. United Kingdom Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 86. United Kingdom Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 87. United Kingdom Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 88. Netherlands Invivo Imaging, by Application USD Million (2016-2021)
  • Table 89. Netherlands Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 90. Netherlands Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 91. Netherlands Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 92. Rest of Europe Invivo Imaging, by Application USD Million (2016-2021)
  • Table 93. Rest of Europe Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 94. Rest of Europe Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 95. Rest of Europe Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 96. MEA Invivo Imaging, by Country USD Million (2016-2021)
  • Table 97. MEA Invivo Imaging, by Application USD Million (2016-2021)
  • Table 98. MEA Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 99. MEA Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 100. MEA Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 101. Middle East Invivo Imaging, by Application USD Million (2016-2021)
  • Table 102. Middle East Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 103. Middle East Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 104. Middle East Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 105. Africa Invivo Imaging, by Application USD Million (2016-2021)
  • Table 106. Africa Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 107. Africa Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 108. Africa Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 109. North America Invivo Imaging, by Country USD Million (2016-2021)
  • Table 110. North America Invivo Imaging, by Application USD Million (2016-2021)
  • Table 111. North America Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 112. North America Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 113. North America Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 114. United States Invivo Imaging, by Application USD Million (2016-2021)
  • Table 115. United States Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 116. United States Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 117. United States Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 118. Canada Invivo Imaging, by Application USD Million (2016-2021)
  • Table 119. Canada Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 120. Canada Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 121. Canada Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 122. Mexico Invivo Imaging, by Application USD Million (2016-2021)
  • Table 123. Mexico Invivo Imaging, by Technology USD Million (2016-2021)
  • Table 124. Mexico Invivo Imaging, by End Use USD Million (2016-2021)
  • Table 125. Mexico Invivo Imaging, by Material Used USD Million (2016-2021)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Invivo Imaging: by Application(USD Million)
  • Table 138. Invivo Imaging Morphological , by Region USD Million (2022-2027)
  • Table 139. Invivo Imaging Molecular , by Region USD Million (2022-2027)
  • Table 140. Invivo Imaging: by Technology(USD Million)
  • Table 141. Invivo Imaging PET (Positron Emission Tomography) , by Region USD Million (2022-2027)
  • Table 142. Invivo Imaging Diffuse Optical Tomography (DOT) , by Region USD Million (2022-2027)
  • Table 143. Invivo Imaging Biomakers , by Region USD Million (2022-2027)
  • Table 144. Invivo Imaging Other , by Region USD Million (2022-2027)
  • Table 145. Invivo Imaging: by End Use(USD Million)
  • Table 146. Invivo Imaging Imaging & Diagnostics Centers , by Region USD Million (2022-2027)
  • Table 147. Invivo Imaging Hospitals & Clinics , by Region USD Million (2022-2027)
  • Table 148. Invivo Imaging Research Institutes , by Region USD Million (2022-2027)
  • Table 149. Invivo Imaging: by Material Used(USD Million)
  • Table 150. Invivo Imaging Optical , by Region USD Million (2022-2027)
  • Table 151. Invivo Imaging Nuclear , by Region USD Million (2022-2027)
  • Table 152. Invivo Imaging Others , by Region USD Million (2022-2027)
  • Table 153. South America Invivo Imaging, by Country USD Million (2022-2027)
  • Table 154. South America Invivo Imaging, by Application USD Million (2022-2027)
  • Table 155. South America Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 156. South America Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 157. South America Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 158. Brazil Invivo Imaging, by Application USD Million (2022-2027)
  • Table 159. Brazil Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 160. Brazil Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 161. Brazil Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 162. Argentina Invivo Imaging, by Application USD Million (2022-2027)
  • Table 163. Argentina Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 164. Argentina Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 165. Argentina Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 166. Rest of South America Invivo Imaging, by Application USD Million (2022-2027)
  • Table 167. Rest of South America Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 168. Rest of South America Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 169. Rest of South America Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 170. Asia Pacific Invivo Imaging, by Country USD Million (2022-2027)
  • Table 171. Asia Pacific Invivo Imaging, by Application USD Million (2022-2027)
  • Table 172. Asia Pacific Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 173. Asia Pacific Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 174. Asia Pacific Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 175. China Invivo Imaging, by Application USD Million (2022-2027)
  • Table 176. China Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 177. China Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 178. China Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 179. Japan Invivo Imaging, by Application USD Million (2022-2027)
  • Table 180. Japan Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 181. Japan Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 182. Japan Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 183. India Invivo Imaging, by Application USD Million (2022-2027)
  • Table 184. India Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 185. India Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 186. India Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 187. South Korea Invivo Imaging, by Application USD Million (2022-2027)
  • Table 188. South Korea Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 189. South Korea Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 190. South Korea Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 191. Taiwan Invivo Imaging, by Application USD Million (2022-2027)
  • Table 192. Taiwan Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 193. Taiwan Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 194. Taiwan Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 195. Australia Invivo Imaging, by Application USD Million (2022-2027)
  • Table 196. Australia Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 197. Australia Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 198. Australia Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 199. Rest of Asia-Pacific Invivo Imaging, by Application USD Million (2022-2027)
  • Table 200. Rest of Asia-Pacific Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 201. Rest of Asia-Pacific Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 202. Rest of Asia-Pacific Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 203. Europe Invivo Imaging, by Country USD Million (2022-2027)
  • Table 204. Europe Invivo Imaging, by Application USD Million (2022-2027)
  • Table 205. Europe Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 206. Europe Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 207. Europe Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 208. Germany Invivo Imaging, by Application USD Million (2022-2027)
  • Table 209. Germany Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 210. Germany Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 211. Germany Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 212. France Invivo Imaging, by Application USD Million (2022-2027)
  • Table 213. France Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 214. France Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 215. France Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 216. Italy Invivo Imaging, by Application USD Million (2022-2027)
  • Table 217. Italy Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 218. Italy Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 219. Italy Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 220. United Kingdom Invivo Imaging, by Application USD Million (2022-2027)
  • Table 221. United Kingdom Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 222. United Kingdom Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 223. United Kingdom Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 224. Netherlands Invivo Imaging, by Application USD Million (2022-2027)
  • Table 225. Netherlands Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 226. Netherlands Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 227. Netherlands Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 228. Rest of Europe Invivo Imaging, by Application USD Million (2022-2027)
  • Table 229. Rest of Europe Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 230. Rest of Europe Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 231. Rest of Europe Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 232. MEA Invivo Imaging, by Country USD Million (2022-2027)
  • Table 233. MEA Invivo Imaging, by Application USD Million (2022-2027)
  • Table 234. MEA Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 235. MEA Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 236. MEA Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 237. Middle East Invivo Imaging, by Application USD Million (2022-2027)
  • Table 238. Middle East Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 239. Middle East Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 240. Middle East Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 241. Africa Invivo Imaging, by Application USD Million (2022-2027)
  • Table 242. Africa Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 243. Africa Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 244. Africa Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 245. North America Invivo Imaging, by Country USD Million (2022-2027)
  • Table 246. North America Invivo Imaging, by Application USD Million (2022-2027)
  • Table 247. North America Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 248. North America Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 249. North America Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 250. United States Invivo Imaging, by Application USD Million (2022-2027)
  • Table 251. United States Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 252. United States Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 253. United States Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 254. Canada Invivo Imaging, by Application USD Million (2022-2027)
  • Table 255. Canada Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 256. Canada Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 257. Canada Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 258. Mexico Invivo Imaging, by Application USD Million (2022-2027)
  • Table 259. Mexico Invivo Imaging, by Technology USD Million (2022-2027)
  • Table 260. Mexico Invivo Imaging, by End Use USD Million (2022-2027)
  • Table 261. Mexico Invivo Imaging, by Material Used USD Million (2022-2027)
  • Table 262. Research Programs/Design for This Report
  • Table 263. Key Data Information from Secondary Sources
  • Table 264. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Invivo Imaging: by Application USD Million (2016-2021)
  • Figure 5. Global Invivo Imaging: by Technology USD Million (2016-2021)
  • Figure 6. Global Invivo Imaging: by End Use USD Million (2016-2021)
  • Figure 7. Global Invivo Imaging: by Material Used USD Million (2016-2021)
  • Figure 8. South America Invivo Imaging Share (%), by Country
  • Figure 9. Asia Pacific Invivo Imaging Share (%), by Country
  • Figure 10. Europe Invivo Imaging Share (%), by Country
  • Figure 11. MEA Invivo Imaging Share (%), by Country
  • Figure 12. North America Invivo Imaging Share (%), by Country
  • Figure 13. Global Invivo Imaging share by Players 2021 (%)
  • Figure 14. Global Invivo Imaging share by Players (Top 3) 2021(%)
  • Figure 15. Global Invivo Imaging share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. TriFoil Imaging (United States) Revenue, Net Income and Gross profit
  • Figure 18. TriFoil Imaging (United States) Revenue: by Geography 2021
  • Figure 19. Berthold Technologies GmbH & Co.KG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Berthold Technologies GmbH & Co.KG (Germany) Revenue: by Geography 2021
  • Figure 21. New England Biolabs. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. New England Biolabs. (United Kingdom) Revenue: by Geography 2021
  • Figure 23. Bruker (United States) Revenue, Net Income and Gross profit
  • Figure 24. Bruker (United States) Revenue: by Geography 2021
  • Figure 25. Promega Corporation. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Promega Corporation. (United States) Revenue: by Geography 2021
  • Figure 27. ThermoFisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. ThermoFisher Scientific (United States) Revenue: by Geography 2021
  • Figure 29. PerkinElmer Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 30. PerkinElmer Inc.(United States) Revenue: by Geography 2021
  • Figure 31. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. AbbVie Inc. (United States) Revenue: by Geography 2021
  • Figure 33. DiscoveRx Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. DiscoveRx Corporation (United States) Revenue: by Geography 2021
  • Figure 35. Biospace Lab S.A. (France) Revenue, Net Income and Gross profit
  • Figure 36. Biospace Lab S.A. (France) Revenue: by Geography 2021
  • Figure 37. MILabs B.V. (Netherland) Revenue, Net Income and Gross profit
  • Figure 38. MILabs B.V. (Netherland) Revenue: by Geography 2021
  • Figure 39. Global Invivo Imaging: by Application USD Million (2022-2027)
  • Figure 40. Global Invivo Imaging: by Technology USD Million (2022-2027)
  • Figure 41. Global Invivo Imaging: by End Use USD Million (2022-2027)
  • Figure 42. Global Invivo Imaging: by Material Used USD Million (2022-2027)
  • Figure 43. South America Invivo Imaging Share (%), by Country
  • Figure 44. Asia Pacific Invivo Imaging Share (%), by Country
  • Figure 45. Europe Invivo Imaging Share (%), by Country
  • Figure 46. MEA Invivo Imaging Share (%), by Country
  • Figure 47. North America Invivo Imaging Share (%), by Country
List of companies from research coverage that are profiled in the study
  • TriFoil Imaging (United States)
  • Berthold Technologies GmbH & Co.KG (Germany)
  • New England Biolabs. (United Kingdom)
  • Bruker (United States)
  • Promega Corporation. (United States)
  • ThermoFisher Scientific (United States)
  • PerkinElmer Inc.(United States)
  • AbbVie Inc. (United States)
  • DiscoveRx Corporation (United States)
  • Biospace Lab S.A. (France)
  • MILabs B.V. (Netherland)
Select User Access Type

Key Highlights of Report


Jul 2022 171 Pages 66 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Invivo Imaging Market Quantitative research analysis
Global Invivo Imaging Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Invivo Imaging Market is heading robustly to achieve new growth cycle.
The Concentration Rate of Global Invivo Imaging market is dominated by North America Players and may generate healthy valuation by 2027.
  • Preference for the Use of Luminescent Proteins as Fluorescent agent is Driving the Demand for the InVivo Imaging
  • Raised Expenditure of Healthcare Industry particularly for Diagnostics
  • Growing Spending’s on Cancer Research and Developments of InVivo Imaging Techniques
dominated the Invivo Imaging market. This is attributable to growing trend of "Growing Advances in Imaging and Diagnostics"

Know More About Global Invivo Imaging Market Report?

Have a Query? Click Here

Other Related Reports

Ozone Therapy Patch Comprehensive Study by Application (Allergic Dermatosis, Skin Ulcers, Tissue Adipose Diseases, Chronic Wounds, Others), Ozone Infusion (Direct, Indirect, Sparkle), Therapeutic Are...
$ 3800
Portable Xray System Comprehensive Study by Application (Dental X-ray, Bone X-ray, Cardiovascular X-ray, Tumour Detection X-ray, Others), Technology (Radiography (Computed & Digital), Fluoroscopy), S...
$ 3450
Emergency Cricothyrotomy Kits Comprehensive Study by Type (Surgical Emergency Cricothyrotomy Kits, Needle/Percutaneous Emergency Cricothyrotomy Kits), Application (Pediatrics, Adults), Distribution C...
$ 3650
Air/Water Syringe Tips Comprehensive Study by Usage (Reusable, Disposable), End Users (Hospitals, Dental Clinics, Dental Laboratories), Materials (Plastic, Metal), Sales Channel (Online Sales Channel...
$ 3450
Dental Treatment Units Comprehensive Study by Accessories (Delivery System {Swinging Hoses and Hanging Hoses}, Operating Lights, LCD Display, Dental Stools, Patient Chair {Electromechanical, Hydrauli...
$ 3750
Centrifugal Blood Pump Comprehensive Study by Distribution Channel (Online, Offline), Motor Type (Electronic, Mechanical), End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centres), Pump He...
$ 3350